MedPath

Evaluation of regenerative potential of 1.2 percent Rosuvastatin-loaded biodegradable membrane in the treatment of Mandibular furcation defect

Phase 2
Conditions
Health Condition 1: K056- Periodontal disease, unspecified
Registration Number
CTRI/2024/06/069093
Lead Sponsor
Dr Amit Rajabhau Pawar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients diagnosed with mandibular furcation defects.

Willingness to participate and comply with study procedures.

Generally good systemic health.

Non-smokers or willing to abstain during the study.

Provide written informed consent.

Exclusion Criteria

Systemic conditions affecting periodontal healing.

Pregnancy or lactation.

Known allergies or sensitivities to study materials.

Current use of medications interacting with Rosuvastatin or periodontal healing.

Uncontrolled periodontal disease or recent periodontal therapy.

Recent dental procedures in furcation area.

Heavy smoking or unwillingness to abstain.

History of drug or alcohol abuse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath